BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38481591)

  • 1. Impact of Different Surgical Approaches on Morbidity and Mortality in Patients with Borderline Resectable Pancreatic Head Carcinoma.
    Hodzic E; Pusina S; Salibasic M; Rovcanin A; Halilovic E; Herenda N
    Med Arch; 2024; 78(1):29-32. PubMed ID: 38481591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].
    Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I
    Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
    Smoot RL; Zhang L; Sebo TJ; Que FG
    J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.
    Bakkevold KE; Kambestad B
    Ann Surg; 1993 Apr; 217(4):356-68. PubMed ID: 7682052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
    Tachezy M; Bockhorn M; Gebauer F; Vashist YK; Kaifi JT; Izbicki JR
    J Gastrointest Surg; 2011 May; 15(5):829-35. PubMed ID: 21359594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-radical resection versus bypass procedure for pancreatic cancer - a consecutive series and systematic review.
    Tol JA; Eshuis WJ; Besselink MG; van Gulik TM; Busch OR; Gouma DJ
    Eur J Surg Oncol; 2015 Feb; 41(2):220-7. PubMed ID: 25511567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.
    Siddiqui AA; Mehendiratta V; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
    Dig Dis Sci; 2013 Jun; 58(6):1744-50. PubMed ID: 23179157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
    Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D
    Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical palliation of pancreatic carcinoma. Results of a 7 year period].
    Koslowsky TC; Wilke J; Voiss W; Michaelis S; Balta D; Siedek M
    Chirurg; 2001 Jun; 72(6):704-9. PubMed ID: 11469092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Pancreatectomy: Does It Have a Role in the Contemporary Management of Pancreatic Adenocarcinoma?
    Kaiser J; Hackert T; Büchler MW
    Dig Surg; 2017; 34(6):441-446. PubMed ID: 28700995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.
    Hofmann FO; Miksch RC; Weniger M; Keck T; Anthuber M; Witzigmann H; Nuessler NC; Reissfelder C; Köninger J; Ghadimi M; Bartsch DK; Hartwig W; Angele MK; D'Haese JG; Werner J
    BMC Surg; 2022 Nov; 22(1):389. PubMed ID: 36368993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
    Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
    Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical palliation for pancreatic carcinoma.
    Zamboni WA; Fisher KS; Ross DS
    Postgrad Med J; 1991 Apr; 67(786):362-5. PubMed ID: 1712474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.
    Araujo RL; Gaujoux S; Huguet F; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Goodman KA; Allen PJ
    HPB (Oxford); 2013 Aug; 15(8):574-80. PubMed ID: 23458208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.
    Ravikumar R; Sabin C; Abu Hilal M; Bramhall S; White S; Wigmore S; Imber CJ; Fusai G;
    J Am Coll Surg; 2014 Mar; 218(3):401-11. PubMed ID: 24484730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of distal pancreatectomy with celiac axis resection and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer].
    Huang XM; Yin J; Lu ZP; Chen JM; Cai BB; Wu PF; Jiang KR; Miao Y
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):441-448. PubMed ID: 35359085
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.